HYPERLIPIDAEMIA EDUCATION & ATHEROSCLEROSIS RESEARCH TRUST UK
Registered charity 1003904 · accounts filings on the Charity Commission register · also known as H.E.A.R.T UK, HYPERLIPIDAEMIA EDUCATION AND RESEARCH TRUST UK
Helping & supporting patients & healthcare professionals to understand & control cholesterol/blood fat conditions & other heart risks; promoting education & research; working in partnership with government, NHS, industry & other charities; and promoting best practice in addressing inherited & other cholesterol/blood fat problems.
Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts
Financial health, per its FY2025 accounts
The accounts state that total income increased to £1,577,004 from £1,327,980 in the prior year, resulting in a net surplus of £86,663. Per the trustees' report, free reserves of £580,207 are within the stated policy target of 6-9 months' operating expenditure, indicating adequate liquidity. The charity continues to adopt the going concern basis with adequate resources projected for the next twelve months.
Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.
What the accounts disclose
Reserves policy: 6 – 9 months’ worth of operating expenditure (held: £580k)
“We aim to hold free reserves in the range of 6 – 9 months’ worth of operating expenditure.”
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Income distribution from subsidiary
“An income distribution was made from HEART UK Trading Company Limited, a wholly owned subsidiary, to HEART UK of £219,176 (2024: £273,273) being a distribution of 100% of their net profit in the year. At the year end an amount of £69,906 (2024: £64,396) was owed to the subsidiary.” — page 42
Per its FY2025 accounts as filed with the Charity Commission.
Trading subsidiary: HEART UK Trading Company Limited
“We also have a trading subsidiary, HEART UK Trading Company Limited through which the majority of our corporate activity is conducted.”
Per its FY2025 accounts as filed with the Charity Commission.
Accounts audited by Moore Kingston Smith LLP. Discloses 4 of 6 completeness components.
Structured financials (annual return, FY ending 28/02/2026)
Cost of raising funds
£193k
Reported reserves equal ~10.8 months of spending — above the median for charities its size (median 4.8 months; benchmarks).
Per its annual return, cost of raising funds: 10.2% of total income — above the median for charities its size (5.2%) (benchmarks).
Trustee list from the Charity Commission register (current, not historical).
Operates in: Northern Ireland · Scotland · Throughout England And Wales
Income and spending
Common questions
Is HYPERLIPIDAEMIA EDUCATION & ATHEROSCLEROSIS RESEARCH TRUST UK financially healthy?
Per its FY2025 accounts: The accounts state that total income increased to £1,577,004 from £1,327,980 in the prior year, resulting in a net surplus of £86,663. Per the trustees' report, free reserves of £580,207 are within the stated policy target of 6-9 months' operating expenditure, indicating adequate liquidity. The charity continues to adopt the going concern basis with adequate resources projected for the next twelve months. Its FY2025 accounts were audited by Moore Kingston Smith LLP.
Government & lottery funding
Grants to this charity published as open data by government and lottery funders (360Giving).
Funders of similar charities
Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.
Charities like this
Semantically similar by activities and financial character, from our analysed corpus. Compare with THE WILLIAM HARVEY RESEARCH FOUNDATION.
Side by side with its peers
Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.